← European Medicine Shortage Tracker · all medicines

Bleomycin shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Bleomycin currently has availability issues reported in 1 European register: Greece.

Limited availability  ATC L01DC01 · also listed as: Bleomycin · data refreshed 12 September 2026

Key facts

As of 12 September 2026, 1 of the 9 tracked registers list current availability issues for Bleomycin, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-07-03 and has now been open for about 2 months. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. In the WHO ATC classification, Bleomycin is coded L01DC01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇬🇷 GreeceLimited availability
Bleomycin
2026-07-032026-07-15Ν Ι.Φ.Ε.Τ.register ↗

Full report history (1 register entry)

Every individual register entry for Bleomycin in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇬🇷 GRBleomycinLimited availability2026-07-032026-07-15Ν Ι.Φ.Ε.Τ.

Frequently asked

Is Bleomycin currently in shortage in Europe?

Yes. As of 12 September 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.

Where does this Bleomycin availability data come from?

Directly from the official medicines-agency register that lists Bleomycin: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bleomycin — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bleomycin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bleomycin availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bleomycin/">Bleomycin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Bleomycin: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 12 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.